BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28869282)

  • 1. Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations.
    Lee HJ; Kim TW; Kim JM; Kim GW; Ko HC; Kim BS; Kim MB; Kim HS
    Int J Dermatol; 2017 Nov; 56(11):1186-1191. PubMed ID: 28869282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
    Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
    Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
    Shigematsu T; Sorscher M; Dier EC; Berenstein A
    J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
    Yang WH; Xiang XJ; Li HL
    Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
    Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
    J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT; Adams S; Adams K; Hudson DA
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous treatment of orofacial vascular malformations.
    Sindel A; Sayan A; Özgür Ö; Sindel T; Ilankovan V
    Br J Oral Maxillofac Surg; 2018 Apr; 56(3):206-211. PubMed ID: 29422307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations.
    Milbar HC; Jeon H; Ward MA; Mitchell SE; Weiss CR; Cohen BA
    J Vasc Interv Radiol; 2019 Sep; 30(9):1438-1442. PubMed ID: 30956080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
    Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
    Hassan Y; Osman AK; Altyeb A
    Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
    Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Sclerotherapy of Superficial Vascular Malformation Leading to Bleomycin Induced Lung Injury and Lipoid Pneumonia.
    Khera D; Bhatnagar A; Khera PS; Kumar P
    Indian J Pediatr; 2019 Jan; 86(1):97-98. PubMed ID: 29934927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.